Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Sep-24 4:55 PM View:  | Francis Knuettel II CEO, Pres., CFO, Treas & Secty | Chromocell Therapeutics Corp (CHRO) | 13-Sep-24 | Purchase | 3,500 | $0.97 | $3,395.00 | < 1% 544.21K to 547.71K | |
| 16-Sep-24 4:55 PM View: | Francis Knuettel II CEO, Pres., CFO, Treas & Secty | Chromocell Therapeutics Corp (CHRO) | 12-Sep-24 | Purchase | 1,700 | $0.97 | $1,649.00 | < 1% 542.51K to 544.21K | |
| 16-Sep-24 4:56 PM View: | Malamut Richard Director | Chromocell Therapeutics Corp (CHRO) | 12-Sep-24 | Purchase | 10,400 | $0.94 | $9,824.88 | 13% 81.17K to 91.56K | |
| 12-Sep-24 5:35 PM View: | Francis Knuettel II CEO, Pres., CFO, Treas & Secty | Chromocell Therapeutics Corp (CHRO) | 11-Sep-24 | Purchase | 5,500 | $0.94 | $5,170.00 | 1% 537.01K to 542.51K | |
| 12-Sep-24 5:35 PM View: | Francis Knuettel II CEO, Pres., CFO, Treas & Secty | Chromocell Therapeutics Corp (CHRO) | 10-Sep-24 | Purchase | 6,500 | $0.89 | $5,785.00 | 1% 530.51K to 537.01K | |
| 23-Feb-24 5:12 PM View: | Friedberg Ezra M Director | Chromocell Therapeutics Corp (CHRO) | 21-Feb-24 | Option Exercise | 20,641 | $4.80 | $99,076.80 | 4% 500.08K to 520.72K | |
| 23-Feb-24 5:15 PM View: | Davis Todd C Director | Chromocell Therapeutics Corp (CHRO) | 21-Feb-24 | Option Exercise | 29,167 | $4.80 | $140,002.00 | 100% 0 to 29.17K |
